Heading towards the close and the AIM All Share is currently just clinging on to positive territory as softening US tariff fears give markets globally something to cheer. Just after 3pm the index was less than a point higher at 710.06.
- Trellus Health +550%
- Falcon Oil & Gas +22%
- MyHealthChecked +19%
- Thruvision -54%
- Blue Star Capital -33%
Trellus Health LON:TRLS was flagged yesterday off the back of its participation in this week’s JP Morgan healthcare conference but today’s move probably sets a record for this column! Shares are up an eye popping 550% after the company agreed a deal with Johnson & Johnson which comes with an undisclosed upfront fee. The spread is impressively tight but it’s worth mentioning that this only puts the stock back to levels it was trading at in early 2024…
- AIM Market Roundup: Trellus Health, Celadon Pharma, Nahl
- AIM Market Roundup: Blue Star Capital, Trellus Health, Distil
Falcon Oil & Gas [LON:FOG] was 22% higher at our early copy time. This extends the stock’s run higher that started just before Christmas following a drilling completion note. Volumes are elevated but far from exceptional – there may be some sector read across too, amidst oil supply concerns.
MyHealthChecked LON:MHC gets the notable mention, up 19% on the day following news that its phlebotomy checks have been registered in the UK and EU, paving the way to commercialising the service in H1 ’25.
Thruvision LON:THRU was the biggest faller, off 54%. This morning the company announced a strategic review of options in light of limited cash options. Clearly there’s some concern here that equity investors could be left offside by the outcome.
- AIM Market Roundup: Thruvision, Priority Intelligence, Oracle Power
- AIM Market Roundup: CMO, Tungsten West, Rockfire
Blue Star Capital LON:BLU was in second to last place, down 33% but that’s simply reversing Monday’s gains. Whilst stake building announcements may have been behind the move higher, it was also backed off by a wide bid/offer spread.
